The conjunctivitis treatment market is expected to reach a value of USD 4.9 billion globally by 2022, with a compound annual growth rate (CAGR) of 5.1%. Conjunctivitis is an inflammation of the membrane covering the eyeball, affecting the conjunctiva part of the eye during the rainy season. It is easily contagious and rarely negatively affects human eyes. Allergy-related conjunctivitis is very common and primarily occurs during the hay fever season. Different strategies are employed in the market to treat this condition.
Antibiotic eye drops or ointments are frequently used for bacterial conjunctivitis. Antiviral drugs are administered if the conjunctivitis is viral; nevertheless, viral conjunctivitis usually goes away on its own. Lubricating eye drops assist preserve moisture in the eyes and reduce symptoms. It is advised that patients with allergic conjunctivitis use antihistamine eye drops. Steroid eye drops are used to treat patients in severe situations.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/conjunctivitis-treatment-market

Impact of Covid-19
There are multiple effects of the COVID-19 pandemic on the market for conjunctivitis treatments. Restrictions or lockdowns made it more difficult to access medical facilities, which delayed the diagnosis and treatment of conjunctivitis. Due to the pandemic's increased emphasis on hygienic habits, there has been a rise in awareness of eye health, which may be driving up demand for conjunctivitis treatments. Variations in the market have resulted from supply chain disruptions that have affected the timely availability of conjunctivitis treatments.
Growth Drivers
The market for conjunctivitis treatments is expanding as a result of lifestyle modifications and an increase in allergic conjunctivitis cases. The discovery of new medications and treatments through research and development expenditures is another major driver of this market's expansion. The market is expanding because hemorrhagic conjunctivitis is becoming more common. Partnerships with healthcare professionals and heightened awareness campaigns are two more factors propelling the market's expansion. The market is expanding at a substantial rate due to rising awareness of eye-related disorders.
The market is expanding dramatically due to the rise in R&D efforts aimed at obtaining improved treatments. The market is expanding due to rising healthcare costs and technology developments. Globalization, industrialization, and rising air pollution are the main factors propelling the market's expansion. Another reason contributing to the rise is the increasing prevalence of bacterial conjunctivitis infections.
Segmentation
Drug Class
· Antibiotics
· Antivirals
· Antiallergic
· Artificial Tears
Disease Type
· Bacterial
· Chemical
· Viral
· Allergic Conjunctivitis
Route of Administration
· Oral
· Topical
End-User
· Hospital
· Online Pharmacies
· Retail Pharmacies
Regional Outlook
· Asia Pacific
· North America
· Latin America
· Europe
· Middle East and Africa
Key Players
· Novartis AG
· Cipla Limited
· Abbvie Inc
· Dr. Reddy’s Laboratories limited
· Micro Labs Limited
· Ocular Therapeutix Inc
· Akkorn operating company
· Vitaris Inc
· Aurobindo Pharma Limited
· Other Players
For More Information about this Report @ https://www.xresearch.biz/shop/conjunctivitis-treatment-market

About Us: -
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: [email protected]
Phone: +1 718-618-4545